Shenzhen Beike Biotechnology Co., Ltd.
PrivateLast Round
Early Funding
Dec 23, 2014
Est. Valuation
$147.36M
Total Funding Raised
$5.8M
Company Overview
Shenzhen Beike Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was an Early Funding round in December 2014.
Shenzhen Beike Biotechnology Co., Ltd. is a biotechnology company that specializes in the research, clinical translation, and technological advancement of adult stem cell therapies and immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenzhen Beike Biotechnology Co., Ltd. Comparables
Compare Shenzhen Beike Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Boyalife Group | 78% | |
| Celltex Therapeutics Corporation | 75% | |
| Vcanbio Cell & Gene Engineering Corporation | 73% |
For institutional investors. Book with your work email.
Shenzhen Beike Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 23, 2014 | ||||
| Grant | Jan 6, 2010 | ||||
| VC Round | Jan 1, 2008 | ||||
| Grant | Nov 13, 2007 | ||||
| Corporate Funding | Jul 1, 2005 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Shenzhen Beike Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Hong Kong University of Science and Technology | Corporate Funding |
| Jiangsu Department of Science & Technology | Grant |
| 松禾资本 (Green Pine Capital Partners) | VC Round |
| Shenzhen Capital Group | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2014
Closed at $147.36M post-money valuation.
- Jan 6, 2010
$1.8M grant from Jiangsu Department of Science & Technology
For institutional investors. Book with your work email.
Shenzhen Beike Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shenzhen Beike Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Shenzhen Beike Biotechnology Co., Ltd. a public or private company?
Shenzhen Beike Biotechnology Co., Ltd. is a private company.
What is the current stock price of Shenzhen Beike Biotechnology Co., Ltd.?
Shenzhen Beike Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shenzhen Beike Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shenzhen Beike Biotechnology Co., Ltd. worth (valuation)?
Shenzhen Beike Biotechnology Co., Ltd.'s valuation is estimated at $147.4M based on funding round data.
Can I buy Shenzhen Beike Biotechnology Co., Ltd. stock?
Shenzhen Beike Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shenzhen Beike Biotechnology Co., Ltd.'s last funding round?
Shenzhen Beike Biotechnology Co., Ltd.'s most recent funding round was Early Funding on December 23, 2014.
Who are the main investors in Shenzhen Beike Biotechnology Co., Ltd.?
Key investors in Shenzhen Beike Biotechnology Co., Ltd. include The Hong Kong University of Science and Technology, Jiangsu Department of Science & Technology, 松禾资本 (Green Pine Capital Partners), Shenzhen Capital Group.
Will Shenzhen Beike Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shenzhen Beike Biotechnology Co., Ltd..
How can I track Shenzhen Beike Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shenzhen Beike Biotechnology Co., Ltd.'s shares on secondary markets.